Cases 31 - 40 of 61
Janssen Pharmaceutica, N.V. et al v. Mylan Pharmaceuticals, Inc. et al
as 1:2015cv00152
Plaintiff:
Janssen Pharmaceutica, N.V. , Janssen Sciences Ireland UC , Gilead Sciences, Inc. and others
Defendant:
Mylan Pharmaceuticals, Inc. and Mylan, Inc.
Counter_claimant:
Mylan Pharmaceuticals, Inc. and Mylan, Inc.
Counter_defendant:
Gilead Sciences Ireland UC , Gilead Sciences, Inc. , Janssen Pharmaceutica, N.V. and others
Cause Of Action: 35 U.S.C. § 271
GILEAD SCIENCES, INC. et al v. Mylan Inc. et al
as 1:2015cv00149
Plaintiff:
GILEAD SCIENCES, INC. and EMORY UNIVERSITY
Defendant:
Mylan Inc. and Mylan Pharmaceuticals Inc.
Counter_claimant:
Mylan Inc. and Mylan Pharmaceuticals Inc.
Counter_defendant:
EMORY UNIVERSITY and GILEAD SCIENCES, INC.
Cause Of Action: 28 U.S.C. § 1338
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2015cv00145
Plaintiff:
Boehringer Ingelheim Pharmaceuticals, Inc. , Boehringer Ingelheim International GmbH , Boehringer Ingelheim Corporation and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Janssen Biotech, Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2015cv00130
Plaintiff:
Janssen Biotech, Inc. , Janssen Oncology, Inc. and Janssen Research & Development, LLC
Defendant:
Mylan Pharmaceuticals Inc. and Mylan, Inc.
Cause Of Action: 35 U.S.C. § 271
Salix Pharmaceuticals, Inc et al v. Mylan Pharmaceuticals, Inc. et al
as 1:2015cv00109
Plaintiff:
Salix Pharmaceuticals, Inc and Dr. Falk Pharma GmbH
Defendant:
Mylan Pharmaceuticals, Inc. and Mylan, Inc.
Counter_claimant:
Mylan, Inc. and Mylan Pharmaceuticals, Inc.
Counter_defendant:
Dr. Falk Pharma GmbH and Salix Pharmaceuticals, Inc
Cause Of Action: 35 U.S.C. § 271
Noven Pharmaceuticals, Inc. et al v. Mylan Technologies, Inc. et al
as 1:2015cv00069
Plaintiff:
Noven Pharmaceuticals, Inc. and Hisamitsu Pharmaceutical Co., Inc.
Defendant:
Mylan Technologies, Inc. , Mylan Pharmaceuticals, Inc. and Mylan Inc.
Counter_claimant:
Mylan Technologies, Inc. , Mylan Pharmaceuticals, Inc. and Mylan Inc.
Counter_defendant:
Hisamitsu Pharmaceutical Co., Inc. and Noven Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Mylan Inc. et al
as 1:2015cv00004
Plaintiff:
Pfizer Inc. , Wyeth LLC , Pfizer Pharmaceuticals LLC and others
Defendant:
Mylan Inc., Agila Specialties Private Ltd. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Fresenius Kabi USA, LLC v. Agila Specialties Private Limited et al
as 1:2014cv00205
Plaintiff:
Fresenius Kabi USA, LLC
Defendant:
Agila Specialties Private Limited and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Baxter Healthcare Corporation et al v. Agila Specialties Private Limited et al
as 1:2014cv00190
Plaintiff:
Baxter Healthcare Corporation , Baxter International Inc. and Baxter Healthcare S.A.
Defendant:
Agila Specialties Private Limited, Agila Specialty Inc., Agila Specialties Inc. and others
Cause Of Action: 35 U.S.C. § 271
TEVA PHARMACEUTICALS USA, INC. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2014cv00167
Plaintiff:
TEVA PHARMACEUTICALS USA, INC. , TEVA PHARMACEUTICAL INDUSTRIES, LTD. , Teva Neuroscience, Inc. and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Natco Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
